Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Endoskopie in Österreich (Stand 2010)
Kardiologie in Österreich (Stand 2006)
Osteologie in Österreich (Stand 2016)
Fachbücher
Patientenliteratur
Gasser R, Ablasser K, Roessl U, Kraigher-Krainer E, Lewinski D, Mangge H, Mächler H, Trantina-Yates A, Tscheliessnigg KH, Udermann H, Porta S, Friehs I, Scherr E, Brussee H, Gasser S Differential Gene Expression und Nebivolol and Atenolol during Experimental Ischemia in Human Myocardium Journal of Clinical and Basic Cardiology 2008; 11 (1-4): 16-23 PDF Summary Overview
| ||||||||||||||||
Figure/Graphic 4: Nebivolol - Atenolol This figure shows biological processes more than twofold downregulated in the presence of nebivolol but unaffected by atenolol during simulated ischemia (100 % O2 replaced by 100 % N2 perfusion). One can see that, in particular on the level of reverse transcription and T-cell-mediated immunity as well as in the process of angiogenesis, a noteworthy regulation is brought about by nebivolol. |
Figure/Graphic 4: Nebivolol - Atenolol
This figure shows biological processes more than twofold downregulated in the presence of nebivolol but unaffected by atenolol during simulated ischemia (100 % O2 replaced by 100 % N2 perfusion). One can see that, in particular on the level of reverse transcription and T-cell-mediated immunity as well as in the process of angiogenesis, a noteworthy regulation is brought about by nebivolol. |